This interaction prevented the binding of SALL2 to the p21 promoter, leading to the accumulation of inactive SALL2 in SiHa, Caski, and HeLa HR-HPV positive cervical cancer cell lines [146]. This evidence concerns the gene SALL2 and cervical carcinoma.